Cyclodextrins in topical drug formulations: theory and practice.
about
A look at emerging delivery systems for topical drug productsDrug Release from ß-Cyclodextrin Complexes and Drug Transfer into Model Membranes Studied by Affinity Capillary Electrophoresis.New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment.Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia.Molecular inclusion complex of curcumin-β-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel.Use of cyclodextrins as a cosmetic delivery system for fragrance materials: linalool and benzyl acetate.Cyclodextrins in drug delivery: an updated reviewThe use of some nanoemulsions based on aqueous propolis and lycopene extract in the skin's protective mechanisms against UVA radiation.Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.Cyclodextrins in delivery systems: ApplicationsDevelopment and clinical evaluation of clotrimazole-β-cyclodextrin eyedrops for the treatment of fungal keratitisThe Relationship between Solubility and Transdermal Absorption of Tadalafil.Cyclodextrins in drug delivery.Sugammadex: a novel agent for the reversal of neuromuscular blockade.Current perspectives of solubilization: potential for improved bioavailability.Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.Recent advances in intravenous delivery of poorly water-soluble compounds.Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.Docetaxel nanotechnology in anticancer therapy.Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.Cyclodextrin-based hydrogels toward improved wound dressings.Oral bioavailability: issues and solutions via nanoformulations.Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin.Comparison of liposomal and 2-hydroxypropyl-β-cyclodextrin-lidocaine on cell viability and inflammatory response in human keratinocytes and gingival fibroblasts.Pickering emulsions: challenges and opportunities in topical delivery.Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium.Estimating Maximal In Vitro Skin Permeation Flux from Studies Using Non-sink Receptor Phase Conditions.Improvement of tetracaine antinociceptive effect by inclusion in cyclodextrins.Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity.Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.Transdermal delivery of cyclodextrin-solubilized curcumin.Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: in vitro and in vivo evaluation.The application of co-melt-extruded poly(ε-caprolactone) as a controlled release drug delivery device when combined with novel bioactive drug candidates: Membrane permeation and Hanson dissolution studiesEffect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid.Combining strategies to optimize a gel formulation containing miconazole: the influence of modified cyclodextrin on textural properties and drug release.Physicochemical study on microencapsulation of hydroxypropyl-beta-cyclodextrin in dermal preparations.Preparation, characterization and taste-masking properties of microspheres containing azithromycin.Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
P2860
Q28260432-C62BF2A2-685C-4FA1-B045-A5137FDBAB1BQ30315728-3E80D46A-0353-4E0F-89E7-92832CF7DFFDQ30781549-BF8BFCA4-CAAF-403B-9A44-201525E67C1AQ30829560-7C9743C8-B4D3-4446-BFE5-8BC4AC949ED2Q31127973-201EF028-0A40-432B-9C36-C644A01D8E90Q31142238-D3B5BEB5-E937-4DBD-BB6D-CEBEE4ABEDA6Q34563402-FC1505FD-4D8A-497D-BC50-78FB6F1C1A9DQ34626805-54FC02FD-5E32-4241-AFA8-0E562E74222FQ35100405-EB4B892B-CE14-4CF2-9E0D-3ACB44B0DFD4Q35138039-AE0D9BF5-CC34-487B-B694-5B90A9E03E6EQ36195091-83B3869F-5EC8-4B8A-BCBE-4B01F7AD66C3Q36196055-2DD3531B-7795-4868-883F-8BD0CFEFD365Q36316735-D678AC45-C5D7-44ED-9583-DB112B2008DAQ36892812-3ED29A0F-D194-4B0C-BF48-D4FFF960D6F0Q36923086-B42E5F7A-A097-44C5-A59C-DDF7F8B20FB5Q37464166-7EF63D12-AC5F-4341-9486-A348772CB45DQ37639306-4CF9FEB4-E515-4D17-BE48-7DCE5D6DC66EQ37861223-F8BA39AF-DC46-474D-8D29-0D6A2CDF1C0CQ38003964-47CD48B9-3352-451C-BAD1-ABED18A7FB3DQ38114136-10B008CC-B54A-4842-B9D7-7951ACF4D96CQ38126910-C4321660-46CD-42C8-9ECB-31E5CE063D8EQ38349734-2AEDC90B-65E9-44B0-9881-0F3DD720D20BQ38549242-5B0C6C58-8C9C-4083-8608-BD9EDDAF61F5Q38779534-884BAD12-6C1D-41EB-910F-BDD1DB6588C8Q38816059-01AC67A7-33E3-4F37-A867-B067746B2404Q39576550-7170764C-4338-4A0C-B8A9-12B204B53DC9Q39677290-D15B8DCC-3FFC-4452-B670-2044F360B436Q39691001-F4EAC183-40FE-4574-9CD2-81F0036004B7Q39763082-02532FD0-70FA-4A1A-BF96-EB747CD36986Q40245982-3C76A2E7-24E6-42C0-B75E-B9913A8F4DB7Q41195841-748AD48D-D044-4E31-AC92-5660DEC910F7Q41849621-C4F08642-0B42-463D-A485-92CC4636709BQ41989429-1BB4F145-38C4-46C5-B54A-9A724BB5816BQ41996557-09431191-5BE4-411F-AF36-045395953F0DQ42125128-FCAE3628-6537-4C0C-A6BE-F777AF924321Q42380866-E13B5F46-FC10-420D-B6B2-830748420A05Q43202100-5E2C3133-D76A-41AC-959C-F0F1C613C623Q43202105-A399CF8B-8D40-4DF7-8ACA-25BA5BC841F4Q43230731-A2D48D67-379D-4C9B-97DF-C67E7F905771Q43639462-8FE939F4-B76C-4915-9896-A14E648F920B
P2860
Cyclodextrins in topical drug formulations: theory and practice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cyclodextrins in topical drug formulations: theory and practice.
@ast
Cyclodextrins in topical drug formulations: theory and practice.
@en
Cyclodextrins in topical drug formulations: theory and practice.
@nl
type
label
Cyclodextrins in topical drug formulations: theory and practice.
@ast
Cyclodextrins in topical drug formulations: theory and practice.
@en
Cyclodextrins in topical drug formulations: theory and practice.
@nl
prefLabel
Cyclodextrins in topical drug formulations: theory and practice.
@ast
Cyclodextrins in topical drug formulations: theory and practice.
@en
Cyclodextrins in topical drug formulations: theory and practice.
@nl
P1476
Cyclodextrins in topical drug formulations: theory and practice.
@en
P2093
P356
10.1016/S0378-5173(01)00761-X
P407
P577
2001-08-01T00:00:00Z